Revenue
attach_money48M USD
YoY -53.8%
SPROSpero Therapeutics, Inc.$ --
Spero Therapeutics, Inc.
SPRO
$ -
-
You can review earnings summary, quarterly trends, full-year progress, and detailed income statement data.
analyticsIncome Statement Summary
FY2024 Full YearUpdated: 12/31/2024
Operating Income
bar_chart-73M USD
YoY -441.5%
Net Income
verified-69M USD
YoY -400.6%
EPS
pie_chart-1.27USD
YoY -395.3%
Quarterly Performance
Quarterly revenue and net income trend
RevenueOperating IncomeNet Income
No quarterly data available
Full-Year Progress
Net Income Progress424.7%On Track
Revenue Progress20.7M
Revenue Forecast25.5M
Net Income Progress-22.9M
Net Income Forecast-5.4M
Income Statement Details
Item
Revenue
Cost of revenue
Gross profit
Research & development
Selling & marketing
Selling, general and administrative
Other operating expenses
Operating income
Interest expense
Income before tax
Income tax expense
Net income
Unlock Long-Term Income Statement Data
Your current plan allows viewing financial data for the latest 1 year (annual only). Upgrade to the Standard Plan to view up to 3 years (including quarterly data), or the Premium Plan to access all historical data.